HLA-DO polymorphism associated with resistance to type I diabetes detected with monoclonal antibodies, isoelectric point differences, and restriction fragment length polymorphism.
J Exp Med (1986) 164 (3): 938–943.
Currently there are no citedby results. Try again later.
